摘要: This chapter examines a number of closely related economic aspects peripheral vascular disease. One fundamental issue is the costs which disease impose on patients and their families, health service sector society. A framework for estimating cost associated with outlined. Economic in isolation offer poor guide to assessing how resources should be allocated across range possible preventive treatment options. introduced examining benefits options illustrates evaluation increasingly being applied develop more informed approach evaluation. The implications programmes recent changes pricing services are examined. Finally, I consider development explicit priorities challenge this poses prevention management community.